maria Joao S. R.
- Country
- France
- Department
- nuclear medecine
Research Overview
- Evaluation of diagnostic performances of 18F-FDOPA PET KInetics as biomarkers for the improvement of care of MRI Non-contrast enhanced Gliomas : a phase IIIb exploratory trial
- Phase IIb Trial of Everolimus and Lutetium (177Lu) Oxodotreotide in Refractory Grade 2 and 3 Meningioma
- Evaluation of 18F-Fludarabine PET in Initial and Relapsed Assessment of Symptomatic Multiple Myeloma Patients
Data & Insights
Has run more than one trial at 4 of 23 partner sites.
Specializations
Neurological Oncology
The investigator specializes in advanced diagnostic and therapeutic approaches for brain tumors, with particular focus on gliomas and meningiomas. Their work involves innovative imaging techniques and treatment strategies for various grades of neurological malignancies.
- Low-grade glioma assessment
- Meningioma treatment optimization
- Neuro-oncological imaging
Key interests include molecular characterization of brain tumors and advanced PET imaging applications.
Hematologic Oncology
The investigator conducts research in multiple myeloma, focusing on innovative diagnostic approaches and treatment assessment methods. Their work encompasses both initial diagnosis and relapsed disease evaluation.
- Multiple myeloma assessment
- PET imaging in hematologic malignancies
- Treatment response evaluation
Expertise includes advanced imaging techniques for hematologic cancer assessment.
Diagnostic Imaging
The investigator employs advanced PET imaging techniques across multiple oncological applications, utilizing various specialized tracers including 18F-Fludarabine and 18F-FDOPA.
- Novel PET tracer applications
- Diagnostic biomarker development
- Treatment response monitoring
Focus on developing and validating innovative imaging biomarkers for cancer diagnosis and monitoring.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.